Levels of IL-2 were previously found increased in the experimental acute CD (Mateus et al., 2019) and serum of cardiopathic CD patients (Poveda et al., 2014), corroborating our finding for the vehicle-treated group. This evidence concerns the gene IL2 and Cowden disease.